110 related articles for article (PubMed ID: 3381006)
1. Effect of peroxisome proliferating hypolipidemic agents on serum activity levels of arylesterase and cholinesterase in rats and mice.
Butler EG; England PJ; Williams GM
Res Commun Chem Pathol Pharmacol; 1988 Apr; 60(1):125-8. PubMed ID: 3381006
[TBL] [Abstract][Full Text] [Related]
2. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.
Warren JR; Simmon VF; Reddy JK
Cancer Res; 1980 Jan; 40(1):36-41. PubMed ID: 6765917
[No Abstract] [Full Text] [Related]
3. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
Moody DE; Reddy JK
Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
[No Abstract] [Full Text] [Related]
4. NTP Toxicology and Carcinogenesis Studies of Ethylene Thiourea (CAS: 96-45-7) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1992 Mar; 388():1-256. PubMed ID: 12637971
[TBL] [Abstract][Full Text] [Related]
5. Role of hypolipidemic drug clofibrate in altering iron regulatory proteins IRP1 and IRP2 activities and hepatic iron metabolism in rats fed a low-iron diet.
Huang HL; Shaw NS
Toxicol Appl Pharmacol; 2002 Apr; 180(2):118-28. PubMed ID: 11969379
[TBL] [Abstract][Full Text] [Related]
6. An upstream region of the enoyl-coenzyme A hydratase/3-hydroxyacyl-coenzyme A dehydrogenase gene directs luciferase expression in liver in response to peroxisome proliferators in transgenic mice.
Alvares K; Fan C; Dadras SS; Yeldandi AV; Rachubinski RA; Capone JP; Subramani S; Iannaccone PM; Rao MS; Reddy JK
Cancer Res; 1994 May; 54(9):2303-6. PubMed ID: 8162569
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
8. Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators.
Reddy JK; Jirtle RL; Watanabe TK; Reddy NK; Michalopoulos G; Qureshi SA
Cancer Res; 1984 Jun; 44(6):2582-9. PubMed ID: 6372995
[TBL] [Abstract][Full Text] [Related]
9. Two hypolipidemic peroxisome proliferators increase the number of lamellar bodies in alveolar cells type II of the rat lung.
Fringes B; Reith A
Exp Mol Pathol; 1988 Apr; 48(2):262-71. PubMed ID: 3258252
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
11. PPAR alpha mediates peroxisome proliferator-induced transcriptional repression of nonperoxisomal gene expression in mouse.
Motojima K; Peters JM; Gonzalez FJ
Biochem Biophys Res Commun; 1997 Jan; 230(1):155-8. PubMed ID: 9020034
[TBL] [Abstract][Full Text] [Related]
12. Species differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl)phthalate, a peroxisome proliferator.
Hosokawa M; Hirata K; Nakata F; Suga T; Satoh T
Drug Metab Dispos; 1994; 22(6):889-94. PubMed ID: 7895606
[TBL] [Abstract][Full Text] [Related]
13. Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
Numoto S; Furukawa K; Furuya K; Williams GM
Carcinogenesis; 1984 Dec; 5(12):1603-11. PubMed ID: 6149819
[TBL] [Abstract][Full Text] [Related]
14. [Peroxisomes and hypolipidemic agents ].
Heller F; Pourbaix S
Sem Hop; 1982 Jul; 58(28-29):1712-7. PubMed ID: 6289453
[TBL] [Abstract][Full Text] [Related]
15. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin.
Conway JG; Neptun DA; Garvey LK; Popp JA
Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175
[TBL] [Abstract][Full Text] [Related]
16. Genetic differences in enzymes associated with peroxisome proliferation and hydrogen peroxide metabolism in inbred mouse strains.
Butler EG; England PJ; Williams GM
Carcinogenesis; 1988 Aug; 9(8):1459-63. PubMed ID: 3402042
[TBL] [Abstract][Full Text] [Related]
17. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
Reddy J; Svoboda D; Azarnoff D
Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
[No Abstract] [Full Text] [Related]
18. Proliferation of myocardial peroxisomes caused by several agents and conditions.
Zipper J
J Mol Cell Cardiol; 1997 Jan; 29(1):149-61. PubMed ID: 9040030
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents.
Huang Y; Hall IH
Pharmazie; 1996 Apr; 51(4):199-206. PubMed ID: 8628737
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
